Clinical Trial Update: The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER) [Phase 2]

View source ↗

Summary

A Phase-2 trial (CLOVER) evaluating leronlimab with an oral chemotherapy and VEGF-inhibitor-enriched regimen for metastatic colorectal cancer is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Leronlimab (leronlimab)

Snippet

Sponsor: CytoDyn, Inc. | Conditions: Metastatic Colorectal Cancer (mCRC) | Phase 2 | Status: RECRUITING